181 related articles for article (PubMed ID: 33974127)
1. Cytoplasmic DDX3 as prognosticator in male breast cancer.
van der Pol CC; Moelans CB; Manson QF; Batenburg MCT; van der Wall E; Borel Rinkes I; Verkooijen L; Raman V; van Diest PJ
Virchows Arch; 2021 Oct; 479(4):647-655. PubMed ID: 33974127
[TBL] [Abstract][Full Text] [Related]
2. RNA-binding protein DDX3 mediates posttranscriptional regulation of androgen receptor: A mechanism of castration resistance.
Vellky JE; McSweeney ST; Ricke EA; Ricke WA
Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28092-28101. PubMed ID: 33106406
[TBL] [Abstract][Full Text] [Related]
3. Dachshund 1 is Differentially Expressed Between Male and Female Breast Cancer: A Matched Case-Control Study of Clinical Characteristics and Prognosis.
Cui Q; Kong D; Li Z; Ahiable P; Wang K; Wu K; Wu G
Clin Breast Cancer; 2018 Oct; 18(5):e875-e882. PubMed ID: 29478945
[TBL] [Abstract][Full Text] [Related]
4. The prognostic effect of DDX3 upregulation in distant breast cancer metastases.
Heerma van Voss MR; Schrijver WA; Ter Hoeve ND; Hoefnagel LD; Manson QF; van der Wall E; Raman V; van Diest PJ;
Clin Exp Metastasis; 2017 Jan; 34(1):85-92. PubMed ID: 27999982
[TBL] [Abstract][Full Text] [Related]
5. Expression of the RNA helicase DDX3 and the hypoxia response in breast cancer.
Bol GM; Raman V; van der Groep P; Vermeulen JF; Patel AH; van der Wall E; van Diest PJ
PLoS One; 2013; 8(5):e63548. PubMed ID: 23696831
[TBL] [Abstract][Full Text] [Related]
6. Investigating nucleo-cytoplasmic shuttling of the human DEAD-box helicase DDX3.
Brennan R; Haap-Hoff A; Gu L; Gautier V; Long A; Schröder M
Eur J Cell Biol; 2018 Sep; 97(7):501-511. PubMed ID: 30131165
[TBL] [Abstract][Full Text] [Related]
7. DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer.
Su CY; Lin TC; Lin YF; Chen MH; Lee CH; Wang HY; Lee YC; Liu YP; Chen CL; Hsiao M
Oncotarget; 2015 Jul; 6(21):18602-12. PubMed ID: 26087195
[TBL] [Abstract][Full Text] [Related]
8. The DEAD-box RNA helicase DDX3 interacts with DDX5, co-localizes with it in the cytoplasm during the G2/M phase of the cycle, and affects its shuttling during mRNP export.
Choi YJ; Lee SG
J Cell Biochem; 2012 Mar; 113(3):985-96. PubMed ID: 22034099
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic characteristics and prognosis for male breast cancer compared to female breast cancer.
Yao N; Shi W; Liu T; Siyin ST; Wang W; Duan N; Xu G; Qu J
Sci Rep; 2022 Jan; 12(1):220. PubMed ID: 34997151
[TBL] [Abstract][Full Text] [Related]
10. Low/negative expression of DDX3 might predict poor prognosis in non-smoker patients with oral cancer.
Lee CH; Lin SH; Yang SF; Yang SM; Chen MK; Lee H; Ko JL; Chen CJ; Yeh KT
Oral Dis; 2014 Jan; 20(1):76-83. PubMed ID: 23410059
[TBL] [Abstract][Full Text] [Related]
11. Level of Murine DDX3 RNA Helicase Determines Phenotype Changes of Hepatocytes In Vitro and In Vivo.
Sergeeva O; Abakumova T; Kurochkin I; Ialchina R; Kosyreva A; Prikazchikova T; Varlamova V; Shcherbinina E; Zatsepin T
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203429
[TBL] [Abstract][Full Text] [Related]
12. Long CAG repeat sequence and protein expression of androgen receptor considered as prognostic indicators in male breast carcinoma.
Song YN; Geng JS; Liu T; Zhong ZB; Liu Y; Xia BS; Ji HF; Li XM; Zhang GQ; Ren YL; Li ZG; Pang D
PLoS One; 2012; 7(12):e52271. PubMed ID: 23272232
[TBL] [Abstract][Full Text] [Related]
13. Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancer.
Coulson-Gilmer C; Humphries MP; Sundara Rajan S; Droop A; Jackson S; Condon A; Cserni G; Jordan LB; Jones LJ; Kanthan R; Di Benedetto A; Mottolese M; Provenzano E; Kulka J; Shaaban AM; Hanby AM; Speirs V
J Pathol Clin Res; 2018 Oct; 4(4):241-249. PubMed ID: 29956502
[TBL] [Abstract][Full Text] [Related]
14. Expression and Localization of DDX3 in Prostate Cancer Progression and Metastasis.
Vellky JE; Ricke EA; Huang W; Ricke WA
Am J Pathol; 2019 Jun; 189(6):1256-1267. PubMed ID: 30926334
[TBL] [Abstract][Full Text] [Related]
15. Nectin-2 and DDX3 are biomarkers for metastasis and poor prognosis of squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.
Miao X; Yang ZL; Xiong L; Zou Q; Yuan Y; Li J; Liang L; Chen M; Chen S
Int J Clin Exp Pathol; 2013; 6(2):179-90. PubMed ID: 23330003
[TBL] [Abstract][Full Text] [Related]
16. The DEAD-box RNA helicase DDX3 associates with export messenger ribonucleoproteins as well as tip-associated protein and participates in translational control.
Lai MC; Lee YH; Tarn WY
Mol Biol Cell; 2008 Sep; 19(9):3847-58. PubMed ID: 18596238
[TBL] [Abstract][Full Text] [Related]
17. Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment.
Heerma van Voss MR; Vesuna F; Bol GM; Afzal J; Tantravedi S; Bergman Y; Kammers K; Lehar M; Malek R; Ballew M; Ter Hoeve N; Abou D; Thorek D; Berlinicke C; Yazdankhah M; Sinha D; Le A; Abrahams R; Tran PT; van Diest PJ; Raman V
Oncogene; 2018 Jan; 37(1):63-74. PubMed ID: 28869602
[TBL] [Abstract][Full Text] [Related]
18. A double-edged function of DDX3, as an oncogene or tumor suppressor, in cancer progression (Review).
He Y; Zhang D; Yang Y; Wang X; Zhao X; Zhang P; Zhu H; Xu N; Liang S
Oncol Rep; 2018 Mar; 39(3):883-892. PubMed ID: 29328432
[TBL] [Abstract][Full Text] [Related]
19. DDX3, a potential target for cancer treatment.
Bol GM; Xie M; Raman V
Mol Cancer; 2015 Nov; 14():188. PubMed ID: 26541825
[TBL] [Abstract][Full Text] [Related]
20. BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients.
Kwiatkowska E; Teresiak M; Filas V; Karczewska A; Breborowicz D; Mackiewicz A
Clin Cancer Res; 2003 Oct; 9(12):4452-9. PubMed ID: 14555518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]